Home >> About

News & Events

The Moulder Center for Drug Discovery Research was highlighted in Speciality Chemicals Magazine in an article entitled "A Fully Integrated Academic Drug Discovery Center."

Abu Dhabi, United Arab Emirates - Magid Abou-Gharbia served as one of three keynote speakers at the 4th annual Middle East Molecular Biology Congress and Exhibition held under the patronage of H.E. Sheikha Lubna Bint Khalid Al Qasimi  at the Zayed University Convention Center.

Dr. Wendy B. Young, Vice President of Discovery Chemistry, Genentech presented a lecture entitled "From Bench to Clinic: Potent, Selective and Reversible BTK Inhibitors" at Temple University School of Pharmacy

Washington, DC - As part of the American Chemical Society's fall 2017 natioanl meeting, Magid Abou-Gharbia served as one of three participants in the Pharma Leaders Symposium entitled “Working together to make a difference.” 

NEW YORK, June 01, 2017 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that Recensa Therapeutics (http://www.recensatherapeutics.com), which is developing a topical psoriasis treatment designed to reduce oxidative stress, was named “Best in Show” by the audience and “Most Fundable” by the investor panel at MABA's 1st Pitch Life Science event held on May 25, 2017 at Rockefeller University in New York City.

May 31st, 2017: Dr Magid Abou-Gharbia chairs Pharma Outsourcing Best Practices Panel at 2017 ChemSpec Europe Meeting at the Munich Trade Fair Center, Germany.


Dr.Benjamin E Blass and Dr. Daniel J Canney received grant from the Crohn's & Colitis Foundation to study the role of the 5-HT7 receptor in inflammatory bowel disease (IBD).  The three year, $347,490 program entitled “Novel Therapies for the Treatment of Ulcerative Colitis: 5-HT7 Antagonists" will also include Dr. Waliul Khan from McMaster University. Dr. Khan is a leading expert in IBD animal models and pharmacology.

Magid Abou-Gharbia presents keynote address at the 2017 CPhI Connect Conference. His lecture highlighted the issues that face the pharmaceutical industry and possible opportunities to address industry challenges in a changing regulatory and political environment.

Philadelphia, PA February 2, 2017 - A startup emerging from Temple University's School of Pharmacy builds on the work of two of its medicinal chemists and could potentially change the way inflammatory bowel disease is treated.  The company, Praeventix, is advancing a discovery made by the School of Pharmacy’s Daniel Canney and Benjamin Blass of the Moulder Center for Drug Discovery Research.

December 9th, 2016 Philadelphia, PA - The Chemspec Golf Outing is held annually to raise money to support research and educational activities at colleges and universities.  This year, Chemspec donated $18,000 to the Moulder Center's scholarship fund during a ceremony held at Temple University School of Pharmacy.



Temple University

Moulder Center for Drug Discovery Research

Temple University School of Pharmacy
3307 N Broad Street
Philadelphia, PA 19140